innovation partners

Acidophil has established strategic innovation partnerships with Isomerase Therapeutics and New Path Molecular Research focused on applying their unique technologies to problems Acidophil is seeking to address in animal health.

Isomerase Therapeutics utilizes a biosynthetic engineering and semisynthetic chemistry platform to optimize microbial natural products.

New Path Molecular Research utilizes sophisticated machine assisted chemistry tools that specialize in the chemical synthesis of complex functional molecules.